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Figure 1. In vitro chondrogenic differentiation assay (n¼3) (a and b)
Representative stereo microscope images of Overall morphology of
chondrogenic pellets differentiated from control and FOCD BM-MSCs.
Pellets were harvested at day 14. White scale bars¼1 mm. (c and d)
Representative images of toluidine blue staining on the sections of these
corresponding pellets are shown. Scale bars¼200um. (e and f) The images
of immunostaining pellets’ sections with aggrecan antibody are shown.
Figure 2. Confocal microscopy images showing double Staining of
aggrecan (red) and GRP78/Bip (green). Cell nuclei stained with DAPI
(blue). The merged images indicated the relative location of aggrecan and
Bip. Overlapping areas appeared yellow. Scale bar¼20um. Samples were
harvested at day 42.
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Purpose: Familial osteochondritis dissecans (FOCD) is an inherited
cartilage defect characterized by multiple joint involvement, short
stature and early osteoarthritis. We have studied a family from
Northern Sweden (NS) with FOCD over ﬁve generations with all
affected family members having a heterozygous missense mutation
on exon 17 of the aggrecan gene. Privious study showed that this
mutation results in a Val-Met amino acid replacement (V2303) in the
G3 aggrecan C-type lectin domain (CLD). The aims of the study were
to investigate the pathogenesis of FOCD-NS by examining chondro-
genesis of patient-derived bone marrow mesenchymal stem cells
(BM-MSCs) and induced pluripotent stem cells (iPSCs). This approach
has given us a fascinating insight into the cellular pathology of the
condition.
Methods: BM-MSCs were obtained after institutional ethical appro-
val and informed consent from a 33 year-old male healthy donor and
a 49 year-old male patient. The cells were characterized by ﬂow
cytometry and tri-lineage differentiation. Chondrogenic pellets,
derived from control and patient BM-MSCs, were harvested to study
the effects of the mutation on early and late chondrogenesis. Tolui-
dine blue staining was carried out to detect glycosaminoglycan (GAG)
and immunohistochemistry (IHC) used to detect proteins of interest.
The ultrastructure of cell organelles was examined by transmission
electron microscopy (TEM). Mass spectrometry was employed to
analyze the composition of extracellular matrix (ECM). Because of
the difﬁculties in obtaining marrow samples from patients and the
low yield of MSCs from this source, we generated patient-speciﬁc
iPSCs from skin ﬁbroblasts of two FOCD-NS patients, a 25 year-old
son and 49 year-old mother. To assess the pluripotency of iPSCs
generated, RT-PCR for pluripotency genes, teratoma assay and kar-
yotype analysis were performed. One non-patient iPSC line was used
as a positive control in all experiments. To validate the disease
phenotype, cartilage formed in patient iPSC-derived teratoma was
also analyzed.
Results: All BM-MSCs expressed typical surface markers and were
capable of tri-lineage differentiation. Chondrogenic differentiation in
vitro revealed an irregular discoid morphology of patient pellets. An
intracellular distribution of aggrecan in FOCD-NS pellets was observed
at early stages of differentiation. Multiple immuno-staining of aggre-
can and Bip, a marker of rough endoplasmic reticulum (rER), further
conﬁrmed that the mutated aggrecan was retained in the rER during
chondrogenic processing. Membrane expansion of the rER was also
detected in chondrocytes derived from patient BM-MSCs at day 56,
indicating a prolonged folding defect within the organelle. Although
collagen type II was produced by patient chondrocytes, TEM showed
that they failure to assemble a normal ECM. GAGs distribution
appeared normal in patient pellets during early chondrogenesis, which
suggested that the non-mutated aggrecan allele was expressed. We
cultured these pellets for up to 100 days to assess the impact during
tissue maturation. The results of mass spectrometry on protein isolated
from these pellets showed while the aggrecan G1 domain was pre-
sented in equal amounts in both groups, the G2 and G3 domains were
reduced by approximately 50% in the patient pellets. Comparing the
amount of other ECM proteins indicated that the composition of
matrix was markedly different between control and patient. Four
patient-derived iPS cell lines were morphologically, genetically and
functionally similar to human embryonic stem cells. Detection of
aggrecan in the cartilage differentiated from these showed the same
disease phenotype found in chondrogenic pellets derived from the
BM-MSCs.
Conclusion: Our ﬁndings concluded that the V2303 mutation results in
folding defect aggrecan G3 domain, which prevents processing of the
protein core through rER. The accumulation of intracellular aggrecan
results in an enlarged rER area and affects the function of FOCD-NS
chondrocytes in assembling normal ECM. Although the non-mutated
aggrecan was produced to a certain extent, it could not reverse the
pathology of the disease during chondrogenesis. ECM with disrupted
composition and reduced aggrecan levels could affect the mechanical
properties of FOCD-NS cartilage. This study revels how insight into
disease mechanism can be obtained by studying the regulation of dif-
ferentiation of progenitor cells. It also provides, for the ﬁrst time, a
model of inherited osteoarthritic disease based on patient-derived iPS
cells, and sheds further light on the critical role of the CLD in aggrecan
folding and in normal matrix assembly.9
IS LONG-TERM PHYSICAL ACTIVITY SAFE FOR OLDER ADULTS WITH
KNEE PAIN?: A SYSTEMATIC REVIEW
J.G. Quicke, N.E. Foster, M.J. Thomas, M.A. Holden. Keele Univ.,
Staffordshire, United kingdom
Purpose: Knee pain attributable to osteoarthritis (OA) is common in
older adults. Although exercise and physical activity are consistently
recommended for older adults with knee pain in clinical guidelines,
physical activity levels in this population remain low. This may, in part,
be due to concerns over its long-term safety. Common and persisting
narratives regarding joint “wear and tear” may lead to attributions that
physical activity causes further joint damage, whilst pain during activity
may be perceived as an indicator of harm. The aim of this study was to
synthesise existing literature to determine whether long-term physical
activity is safe for older adults with knee pain.
Methods: A comprehensive systematic review was conducted using
multiple electronic databases including MEDLINE, EMBASE, CINAHL,
CENTRAL, AMED, SPORTDiscus, CISDOC, NIOSHTIC-2 and HSELINE from
inception until 16th May 2013. Two reviewers independently screened
all titles, abstracts and full texts for study inclusion and exclusion
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sensus with a third reviewer where necessary.
Inclusion criteria were: a) randomised controlled trials (RCT), pro-
spective cohort studies (PCS) or case control studies (CCS); b) including
adults over 45 years old with knee pain or OA; c) undertaking exercise
or physical activity explicitly over at least three months; and d) meas-
uring a safety related outcome including adverse events, pain, physical
functioning, radiographic or magnetic resonance imaging (MRI) OA
biomarker progression or progression to total knee replacement (TKR).
Included studies were assessed for risk of bias using the Cochrane risk of
bias tool for RCT and the Quality In Prognosis Studies risk of bias tool for
PCS and CCS. Safety data were extracted and analysed by narrative
synthesis.
Results: In total, 8605 unique references were identiﬁed by the search
and 37 primary studies were included in the review. The included
studies were made up of 35 RCT, 1 PCS and 1 CCS, which were under-
taken in 16 different countries and were of variable quality. In total,
7194 older adults with either knee pain or clinical, radiographic and
combined OA diagnoses were included. The 35 RCT investigated a
variety of exercise and physical activity interventions including: walk-
ing, Tai Chi, aerobics, strengthening, ﬂexibility, balance, and exercise in
water, of between three months and two years duration. 15 studies
provided data on adverse events, 35 on pain, 32 physical functioning
and 5 some form of radiographic orMRI biomarker of OA progression. In
terms of safety results, only eight serious adverse events were reported:
one inguinal hernia, ﬁve falls (one of which resulted in a head laceration
injury and one a fractured radius), one participant fractured her foot as a
result of dropping a weight and one had an exacerbation of existing
back pain. Mild adverse events of increase in knee pain occurred in a
minority of individuals in eight RCT. There was no evidence of a stat-
istically signiﬁcant increase in pain, decrease in physical function, or
deterioration in radiographic or MRI ﬁndings (compared to either
control group at follow up orwithin the same group comparing baseline
to post treatment data). The single, moderate risk of bias, CCS inves-
tigated factors associated with OA progression to TKR in Finnish older
adults. It concluded that increasing levels of regular exercise were
associated with less chance of progression when compared to those
who did not carry out regular exercise. The single, high risk of bias, PCS
investigated occupational physical activity exposure in older adult
members of a French energy company. From a set of 10 physical activity
variables, only prolonged exposure to kneeling and squatting activities
(between 1 and 25 years) was associated with severe knee pain
(Adjusted OR 1.4 95% CI 1.04,1.85). Overall risk of bias across studies was
variable with performance, attrition, and reporting bias frequently
being unclear.
Conclusions: This systematic review demonstrates that long-term
exercise and physical activity, lasting three months or more, is safe for
older adults with existing knee pain or OA. Serious adverse events with
exercise are very rare. However, the risk of bias of included studies was
often a concern.
These ﬁndings match existing expert consensus regarding the safety of
exercise and current recommendations for exercise and physical
activity as “core” treatments in clinical guidelines.
10
BIOACTIVITY IN AN AGGRECAN 32MER FRAGMENT IS MEDIATED VIA
TOLL-LIKE RECEPTORS
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Purpose: One naturally-occurring fragment of aggrecan catabolism is
the 32mer fragment derived from the aggrecan interglobular domain
following cleavage by both ADAMTS and MMP enzymes. The aim of this
study was to determine whether the aggrecan 32mer fragment was
bioactive, and if so, to elucidate the mechanism.
Methods: Mouse femoral head cartilage explants, epiphyseal chon-
drocytes, synovial ﬁbroblasts or peritoneal macrophages were cultured
for 24 hours in the presence of synthetic mouse 32mer (FFGVGGED-
DITIQTVTWPDLELPLPRNVTEGE; Auspep, Australia) or a scrambled
peptide comprising the same amino acids in a random order. Global
gene expression in explants treated with IL-1a or 32mer was compared
on Illumina mouse W6-6_V2 expression beadchips. Thereafter, changesin gene and protein expression were validated in cell and explant cul-
tures by qPCR, IL-6 ELISA and gel zymography.
Results: In the microarray experiment, 32mer-treated cartilage
explants decreased their expression of genes encoding matrix proteins
and increased their expression of pro-inﬂammatory/pro-catabolic
genes. The results showed that the pattern of genes that were up- and
down-regulated by IL-1a and 32mer treatment were strikingly similar.
Validation by qPCR conﬁrmed that the 32mer, but not a scrambled
32mer peptide, regulated gene expression in articular chondrocytes,
peritoneal macrophages and synovial ﬁbroblasts from wildtype mice.
The levels of IL-6 measured by ELISA and gelatinase activity measured
by gel zymography were also signiﬁcantly increased in cells treated
with 32mer or IL-1a, but not the scrambled peptide. The striking cor-
relation in the pattern of genes regulated by IL-1a and 32mer treatment
raised the possibility that IL-1a and the 32mer might share components
of a signalling pathway; for example MyD88 is an essential adaptor
protein for both the IL-1 receptor andmost Toll-like receptors (TLR). We
therefore compared cells from wildtype mice and MyD88 null mice for
the effects of 32mer stimulation and found that neither gene expression
nor levels of IL-6 cytokine were increased in cells harvested from mice
lacking MyD88, suggesting that the 32mer might be an activator of TLR
signalling. We next compared the effect of 32mer treatment on mac-
rophage cell lines derived from wildtype, TLR2 or TLR4 null mice and
found that whereas stimulation with the 32mer was identical in wild-
type and TLR4 null cells, the 32mer failed to signal in TLR2 null cells.
These results strongly suggest that the aggrecan 32mer is a ligand for
TLR2. We next used complementary hydropathy to derive an antigenic
sequence for raising an antibody (aCG11) against a putative 32mer-
binding protein, then used aCG11 immunoafﬁnity chromatography to
isolate the putative 32mer-binding protein from 4M GuHCl extracts of
human OA and juvenile cartilage. Mass spectrometry analyses identi-
ﬁed PRELP, a small leucine-rich repeat proteoglycan, as the major
molecule binding to and eluting from the immunoafﬁnity column in
both samples, and this was conﬁrmed byWestern blotting with aPRELP
antibodies. Decorin and biglycan are also members of the small leucine-
rich repeat proteoglycan family; they are related to PRELP, and both
have been identiﬁed as TLR2 and TLR4 ligands. Further experiments to
resolve the biological role of PRELP in 32mer-mediated TLR activation in
chondrocytes, synovial ﬁbroblasts and macrophages are in progress.
Conclusions: These studies identify the aggrecan 32mer as an endog-
enous activator of TLR2-mediated immunity with the potential to
accelerate inﬂammation and cartilage destruction in vivo.
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DECORIN-DEFICIENT MICE ARE LESS PRONE TO DEVELOP
OSTEOARTHRITIS AFTER FORCED EXERCISE
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Purpose: Here we analyzed the impact of decorin-deﬁciency (Dcn-/-)
on the biomechanical properties of cartilage and the osteoarthritis
development in a mouse model via forced exercise on a treadmill. In
articular cartilage, the small leucine-rich proteoglycan decorin (Dcn) is
located within the interterritorial regions of the extracellular matrix
(ECM), where it is associated with thick, well-banded collagen ﬁbrils.
Inside the ECM, decorin binds and inactivates TGF-b and thereby reg-
ulates the activity of this cytokine, which is known to inﬂuence the
sulfation of glycosaminoglycan (GAG) chains.
Methods: Osteoarthritis (OA) was induced in three month-old Dcn-/-
and WT mice via forced running on a treadmill and the severity was
scored by a modiﬁed Mankin score. To analyze biomechanical proper-
ties, knee cartilage of Dcn-/- mice and wild-type (WT) mice was
examined at different developmental stages by histology, immunohis-
tochemistry, and atomic force microscopy (AFM). The amount of active
TGF-b1 in the supernatant of cultured Dcn-/- andWTchondrocytes was
analyzed by ELISA. Expression of GAGmodifying enzymes was assessed
by semi-quantitative RT-PCR.
